Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new non-invasive prenatal diagnosis of Down syndrome through epigenetic markers and real-time qPCR

14 Apr 2012

Abstract excerpt

INTRODUCTION: Non-invasive prenatal diagnosis (NIPD) of Down syndrome is rapidly evolving. Currently, two applications for NIPD of Down syndrome have been developed with potential and have displayed positive results; the NIPD using next-generation sequencing technologies and the NIPD using the methylated DNA immunoprecipitation (MeDIP) real-time quantitative polymerase chain reaction (qPCR). AREAS COVERED: The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Down syndrome and intellectual disability research
Share to Gestational Trophoblastic Disease Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22500647
DOI: 10.1517/14712598.2012.674108

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new non-invasive prenatal diagnosis of Down syndrome through epigenetic markers and real-time qPCRPMID 22500647Read ↗

Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndromeSemantic proximity Read ↗

Prenatal diagnosis and pregnancy outcomes in high-risk and borderline high-risk pregnant women for Down syndromeSemantic proximity Read ↗

Non‐invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowlySemantic proximity Read ↗

Has Noninvasive Prenatal Testing Impacted Termination of Pregnancy and Live Birth Rates of Infants With Down Syndrome?Semantic proximity Read ↗

Selection and evaluation of DNase I hypersensitive sites for prenatal screening of trisomy 21 in the fetusSemantic proximity Read ↗

The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesisSemantic proximity Read ↗

Proteomics and Down syndrome screening: a validation studySemantic proximity Read ↗

Genome-wide miRNA profiling in plasma of pregnant women with Down syndrome fetusesSemantic proximity Read ↗

Genome-wide miRNA profiling in plasma of pregnant women with down syndrome fetusesSemantic proximity Read ↗

Single-cell multi-omics map of human fetal blood in Down syndrome.Semantic proximity Read ↗

MeDIP real‐time qPCR of maternal peripheral blood reliably identifies trisomy 21Semantic proximity Read ↗

Prenatal Screening and Diagnosis: Time for a Paradigm ShiftSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.